Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
source: pixabay.com
Hundreds of mutations have been connected to autism spectrum disorder (ASD), and a new study finds further evidence that suggests a possible cause of this spectrum of conditions Neuroscience News…
Continue Reading
New Study: Mitochondria Defects in Brain Cells Might Cause Autism Spectrum Disorder
The COVID pandemic affecting eighty-million children in the nation has been a burden on many families. A number that deserves attention is the seven million students who have learning disabilities.…
Continue Reading
Special Needs Students Deserve Quality Online Education
source: pixabay.com
Improving cognition and identifying abnormal molecular pathways in Alzheimer’s disease has been challenging. Current studies of Alzheimer’s disease have focused on reducing such occurrences as amyloid plaque, neuroinflammation, and neurofibrillary…
Continue Reading
Neuroscientists Are Focusing on Synthetic Pharmaceuticals to Restore Cognitive Function in Alzheimer’s Disease
The NZ Herald recently published details about the experience of seven-year-old Logan Walsh of Leeds, England. His mother was told to take Logan home after he had been diagnosed with…
Continue Reading
The Truth About COVID’s Threat to Children After Recovery
Tara Johnston, a resident of London, England is now twenty years old but still coping with severe acne. Tara interviewed with MyLondon in an effort to raise awareness and share…
Continue Reading
Acceptance by Peers Can Be Difficult With Cystic Acne
Dr. Andrew Brunner, an oncologist at Massachusetts Cancer Center was recently interviewed by Targeted Oncology. The discussion centered around a phase 1b clinical trial (NCT03066648) investigating sabatolimab together with hypomethylating…
Continue Reading
Sabatolimab Can Be Added Safely to Hypomethylating Agents in the Treatment of MDS and AML
source: pixabay.com
Toxoplasmosis is transmitted by Toxoplasma gondii, the protozoan parasite which is known to be among the most common parasites worldwide. The infection occurs from contaminated meat, cat feces that…
Continue Reading
A Common Parasite With An Uncommon Name: Toxoplasma gondii is Associated with Brain Cancer
A team of German Scientists is offering hope for people who have sports, traffic, or war-related injuries of the spinal cord. According to a recent article in Neuroscience News, these…
Continue Reading
Paralyzed Mice Can Walk Again Thanks to a Novel Designer Drug
Parkinson’s News Today recently featured an upbeat article describing the progress that researchers have made in developing a method of measuring alpha-synuclein’s (AS) progression that cuts discovery time in…
Continue Reading
New Parkinson’s Test Gets Results in Half the Time With Improved Accuracy
source: pixabay.com
There are many common elements in Alzheimer’s disease (AD), which is the most common type of dementia. It is now evident that there are varied spans of disease progression…
Continue Reading
Discovery of Three Molecular Subtypes Brings Us Closer to Unraveling Alzheimer’s Disease
Although advances in lung cancer care were overshadowed this year by news about the pandemic, Dr. Jennifer Carlisle’s recent interview with Oncology gave details of spectacular advances in lung cancer…
Continue Reading
2020 Brought Exciting Advances in Lung Cancer Care
Sorafenib, a tyrosine kinase inhibitor, has been unbeatable for treating cancer of the liver for the past thirteen years. An article by the Cleveland Clinic stated that during that time,…
Continue Reading
A Giant Step Forward in Treating Hepatocellular Carcinoma
Over the past decade, scientists have made many life-saving advances in all areas of medicine. They have created molecular agents to target neurodegenerative diseases. But they were stopped right there…
Continue Reading
A New Method of Delivering Drugs Through the Blood-Brain Barrier To Treat Neurological Disorders
source: pixabay.com
Researchers at Johns Hopkins School of Medicine noted that osteonecrosis (ON) is one of the more serious complications of systemic lupus erythematosus (SLE). According to a recent article in…
Continue Reading
Increased Risk of Osteonecrosis in Lupus May be Caused by Prednisone
The medical community has been aware for some time now that patient involvement in his or her treatment is a critical part of therapeutic development. Biopharmaceutical companies acknowledge their obligation…
Continue Reading
The FDA and Biopharmaceutical Companies Are Encouraging Patient Involvement
Neuroscience News recently carried an article heralding reports of researchers' finding that upwards of twenty percent of lethal glioblastoma brain cancers may be treatable by newly developed drugs. Currently, the…
Continue Reading
New Finding: Overactive Mitochondria Are Responsible for Twenty Percent of Glioblastoma Brain Cancers
The statistics are grim. A survey of 12,000 US nursing homes finds over 56,000 COVID related deaths as of July 2020. This number represents ten percent of all cases in…
Continue Reading
Determining Risk Factors At Nursing Homes for COVID-19
source: pixabay.com
According to a recent article in Statnews, providers must obtain prior authorization from an insurer for several reasons; to start, the insurer often requires physicians to justify prescribing a…
Continue Reading
Doctors Question Insurers’ Requirements for Prior Authorization
source: pixabay.com
CBC News recently interviewed Amanda, Bradley, and Brad Bright, a close-knit black family living in Nova Scotia. The Brights explain that working their way through initial diagnosis and treatment…
Continue Reading
This Family May be the Only Canadians with Camurati-Engelmann Disease
source: pixabay.com
While novel treatments have been rapidly emerging onto the drug scene, new treatment options for pancreatic cancer have fallen behind. But now, according to OncLive’s interview with Dr. P.A. Philip,…
Continue Reading
Experimental Treatment Could be Useful in Numerous Rare and Deadly Cancers
source: pixabay.com
Parents of children who have received a diagnosis of Hutchinson-Gilford progeria syndrome (HGPS) may be relieved to learn the FDA recently approved Zokinvy capsules that were developed to lower…
Continue Reading
The First Treatment Has Been Approved For Hutchinson-Gilford Progeria Syndrome
source: pixabay.com
The initial CRISPR treatment for sickle cell disease was administered to Victoria Gray in July 2019. Victoria, a resident of Forest, Mississippi, was born with sickle cell and has…
Continue Reading
Patients Who Received CRISPR Gene Editing for Beta Thalassemia and Sickle Cell Disease Remain Pain Free
Sourced from Pixabay
Neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and multiple sclerosis are disorders that mostly affect the neurons located in the brain. These diseases are incurable, resulting in the death of nerve…
Continue Reading
The Role of Retroviruses and Other Risk Factors In Multiple Sclerosis
Toxicity resulting from cancer therapy is usually the result of the repeated administration of cancer drugs. On the other hand, the efficacy of CRISPR-Cas9 has been largely affected by problematic…
Continue Reading
CRISPR-Cas9’s Gene Editing Potential in Cancer Therapy
source: pixabay.com
A recent announcement by Gilead Company citing data from Kite Pharma, one of its premier companies, set out remarkable results from Kite’s Zuma-1 clinical trial. The findings confirmed that…
Continue Reading
Infusion of Yescarta Resulted in 44 Percent 4-year Overall Survival Rate in Large B-cell Lymphoma